| Issue |
Title |
File |
| Vol 94, No 7 (2022) |
Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT) |
(Rus)
|
|
Ptushkin V.V., Kunst M.A., Mitina T.A., Konstantinova T.S., Rachkova N.N., Shelekhova T.V., Elykomov I.V., Kuchma G.B., Farizova K.O., Vinogradova O.Y., Nikitin E.A., Pashanov E.D.
|
| Vol 94, No 7 (2022) |
Нospital outcomes of coronary artery bypass grafting in patients with coronary heart disease with previous percutaneous coronary intervention |
(Rus)
|
|
Kremneva L.V., Suplotov S.N., Abaturova O.V., Stognii N.I., Shalaev S.V.
|
| Vol 94, No 7 (2022) |
Combined use of the GRACE ACS risk score and comorbidity indices to increase the effectiveness of hospital mortality risk assessment in patients with acute coronary syndrome |
(Rus)
|
|
Zykov M.V., Dyachenko N.V., Velieva R.M., Kashtalap V.V., Barbarash O.L.
|
| Vol 94, No 7 (2022) |
Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry) |
(Rus)
|
|
Oschepkova E.V., Aksenova A.V., Orlovsky A.А., Chazova I.E.
|
| Vol 94, No 7 (2022) |
Biochemical markers of thrombotic complications in the acute period of ischemic stroke |
(Rus)
|
|
Kochetov A.G., Lyang O.V., Zhirova I.A., Ivoylov O.O.
|
| Vol 94, No 7 (2022) |
Seх differences in treatment of acute coronary syndrome patients. Data from federal registry of acute coronary syndrome 2016–2019 |
(Rus)
|
|
Sagaydak O.V., Oschepkova E.V., Chazova I.E.
|
| Vol 94, No 6 (2022) |
Impact of kidney biopsy on the management of patients in the rheumatology department: retrospective study |
(Rus)
|
|
Kokhanchuk V.A., Skvortsov A.V., Shchegoleva E.M., Kuznetsova E.I., Novikov P.I., Stoliarevich E.S., Varshavsky V.A., Moiseev S.V., Bulanov N.M.
|
| Vol 94, No 6 (2022) |
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study |
(Rus)
|
|
Milovanova L.Y., Taranova M.V., Volkov A.V., Milovanova S.Y., Beketov V.D.
|
| Vol 94, No 6 (2022) |
New opportunities for neuroprotective therapy of patients in the acute and early recovery period of ischemic stroke |
(Rus)
|
|
Tanashyan M.M., Raskurazhev A.A., Zaslavskaya K.I., Kuznetsova P.I., Merkulova I.Y.
|
| Vol 94, No 6 (2022) |
Risk factors of kidney injury in patients with COVID-19 |
(Rus)
|
|
Shchepalina A.A., Chebotareva N.V., Kitbalian A.A., Potapov P.P., Nartova A.A., Akulkina L.A., Brovko M.Y., Sholomova V.I., Moiseev S.V.
|
| Vol 94, No 6 (2022) |
Evaluation of hemostasis disorders using the thrombodynamic test in patients with chronic glomerulonephritis with nephrotic syndrome |
(Rus)
|
|
Berns A.S., Sovetnikov E.N., Chebotareva N.V., Berns S.A., Solonkina A.D., Guliaev S.V., Kraeva V.V., Moiseev S.V.
|
| Vol 94, No 6 (2022) |
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5 |
(Rus)
|
|
Dzgoeva F.U., Remizov O.V., Botcieva V.K., Goloeva V.G., Malakhova N.G., Ikoeva Z.R.
|
| Vol 94, No 6 (2022) |
Urinary biomarkers of kidney injury in patients treated with anti-VEGF drugs |
(Rus)
|
|
Grechukhina K.S., Chebotareva N.V., Zhukova L.G., Androsova T.V., Karpov V.V., Krasnova T.N.
|
| Vol 94, No 6 (2022) |
Remissions and progression of C3 glomerulopathy |
(Rus)
|
|
Karunnaya A.V., Dobronravov V.A.
|
| Vol 94, No 5 (2022) |
Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit |
(Rus)
|
|
Markina U.A., Fomina D.S., Lebedkina M.S., Kruglova T.S., Chernov A.A., Zagrebneva A.I., Mutovina Z.Y., Karaulov A.V., Alexeeva E.I., Lysenko M.A.
|
| Vol 94, No 5 (2022) |
Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment |
(Rus)
|
|
Khripun A.I., Starshinin A.V., Antipova Y.O., Lysenko M.A., Urozhaeva Y.V., Gavrilenko O.F., Rusantsova N.A., Tyazhelnikov A.A., Tikhonovskaya E.Y., Okolot N.V., Sokolova M.V., Fomina D.S., Simonova E.N., Kruglova T.S., Chernov A.A., Zagrebneva A.I.
|
| Vol 94, No 5 (2022) |
Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results |
(Rus)
|
|
Galushko E.A., Gordeev A.V., Matyanova E.V., Olyunin Y.A., Nasonov E.L.
|
| Vol 94, No 5 (2022) |
Phenotypes of body composition, physical performance and quality of life in women with rheumatoid arthritis |
(Rus)
|
|
Dobrovolskaya O.V., Toroptsova N.V., Feklistov A.Y., Demin N.V., Sorokina A.O., Nikitinskaya O.A.
|
| Vol 94, No 5 (2022) |
Activity of ankylosing spondylitis in women within one year after childbirth |
(Rus)
|
|
Krichevskaya O.A., Dubinina T.V., Ilinykh E.V., Glukhova S.I., Demina A.B., Andrianova I.A.
|
| Vol 94, No 5 (2022) |
Achievement of clinical-laboratory and ASAS-partial remission in patients with early axial spondyloarthritis according to the ESAC cohort at the 3rd year of follow-up |
(Rus)
|
|
Timokhina D.G., Dubinina T.V., Demina A.B., Krichevskaya O.A., Erdes S.F.
|
| Vol 94, No 5 (2022) |
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugs |
(Rus)
|
|
Korolev M.A., Letyagina E.A., Sizikov A.E., Bogoderova L.A., Ubshaeva Y.B., Omelchenko V.O., Akimova A.A., Mullagaliev A.A., Chumasova O.A., Kurochkina Y.D.
|
| Vol 94, No 5 (2022) |
Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome |
(Rus)
|
|
Reshetnyak T.M., Cheldieva F.A., Cherkasova M.V., Lila A.M., Nasonov E.L.
|
| Vol 94, No 5 (2022) |
The burden of progression of psoriatic arthritis. All-Russian register data |
(Rus)
|
|
Korsakova Y.L., Loginova E.Y., Korotaeva T.V., Gubar E.E., Glukhova S.I., Vasilenko E.A., Nasonov E.L.
|
| Vol 94, No 5 (2022) |
Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis |
(Rus)
|
|
Abramkin A.A., Lisitsyna T.A., Veltishchev D.Y., Seravina O.F., Kovalevskaya O.B., Glukhova S.I., Nasonov E.L.
|
| Vol 94, No 5 (2022) |
Evaluation of the association of polymorphisms of the CYP2C8 gene with the efficacy and safety of ketorolac in patients with postoperative pain syndrome |
(Rus)
|
|
Muradian A.A., Sychev D.A., Blagovestnov D.A., Petrov D.I., Skukin D.S., Epifanova I.P., Sozaeva Z.A., Kachanova A.A., Denisenko N.P., Abdullaev S.P., Grishina E.A.
|
| Vol 94, No 4 (2022) |
Myocardial scintigraphy with 99mTc-pyrophosphate in the diagnosis of cardiac amyloidosis: place in the diagnostic algorithm, features of the implementation and interpretation of the study |
(Rus)
|
|
Ansheles A.A., Nasonova S.N., Zhirov I.V., Saidova M.A., Stukalova O.V., Tereshchenko S.N., Sergienko V.B.
|
| Vol 94, No 4 (2022) |
Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board |
(Rus)
|
|
Avdeev S.N., Emelyanov A.V., Aisanov Z.R., Sinopalnikov A.I., Fomina D.S., Nenasheva N.M., Leshchenko I.V., Zaikova-Khelimskaia I.V., Vizel A.A., Demko I.V., Shaporova N.L., Shulzhenko L.V., Shabanov E.A.
|
| Vol 94, No 4 (2022) |
The possibilities of improving the treatment of chronic heart failure according to the results of a multicenter observational study BYHEART |
(Rus)
|
|
Tereshchenko S.N., Cheremisina I.A., Safiullina A.A.
|
| Vol 94, No 4 (2022) |
Zonulin and I-FABP are markers of enterocyte damage in celiac disease |
(Rus)
|
|
Bykova S.V., Sabelnikova E.A., Novikov A.A., Baulo E.V., Khomeriki S.G., Parfenov A.I.
|
| Vol 94, No 4 (2022) |
Predictive value of QRS complex duration in patients with chronic heart failure and atrial fibrillation: retrospective study |
(Rus)
|
|
Uskach T.M., Sharapova Y.S., Safiullina A.A., Zinovyeva E.V., Tereshchenko S.N.
|
| Vol 94, No 4 (2022) |
Organizing pneumonia as a pulmonary manifestation of post-COVID syndrome: features of diagnosis and treatment |
(Rus)
|
|
Akulkina L.A., Shchepalina A.A., Kitbalian A.A., Potapov P.P., Moiseev A.S., Brovko M.Y., Sholomova V.I., Moiseev S.V.
|
| Vol 94, No 4 (2022) |
Proinflammatory laboratory predictors of pneumonia in ischemic stroke patients: prospective study |
(Rus)
|
|
Kochetov A.G., Lyang O.V., Zhirova I.A., Ivoylov O.O., Politidis R.R., Novozhenova Y.V.
|
| Vol 94, No 4 (2022) |
A new approach in the diagnosis of lung lesions in patients with COVID-19: lung ultrasound protocol versus CT scan |
(Rus)
|
|
Saidova M.A., Avalyan A.A., Galaeva M.A., Belkind M.B.
|
| Vol 94, No 4 (2022) |
The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients |
(Rus)
|
|
Klesareva E.A., Afanasieva O.I., Sherstyuk E.E., Tmoyan N.A., Razova O.A., Tyurina A.V., Afanasieva M.I., Ezhov M.V., Pokrovsky S.N.
|
| Vol 94, No 4 (2022) |
Transthyretin amyloid cardiomyopathy. Features of histological diagnosis: study design |
(Rus)
|
|
Guselnikova V.V., Fedorova E.A., Gudkova A.J., Shavlovsky M.M., Korzhevskii D.E.
|
| Vol 94, No 4 (2022) |
Prognostic significance of equivalent density of calcium deposits of coronary arteries in men with osteopenic syndrome and prior coronary artery bypass grafting: prospective study |
(Rus)
|
|
Kokov A.N., Masenko V.L., Barbarash O.L.
|
| Vol 94, No 3 (2022) |
Hydrogen effect on the mechanisms of mucosal immunity in patients with COVID-19 |
(Rus)
|
|
Svitich O.A., Baranova I.A., Kryukova N.O., Poddubikov A.V., Vinnitskaya A.B., Abramova N.D., Zakharova V.V., Shogenova L.V., Kostinov M.P., Chuchalin A.G.
|
| Vol 94, No 3 (2022) |
Long-term follow-up study of post-COVID-19 patients |
(Rus)
|
|
Karchevskaya N.A., Skorobogach I.M., Cherniak A.V., Migunova E.V., Leshchinskaya O.V., Kalmanova E.N., Bulanov A.I., Ostrovskaya E.A., Kostin A.I., Nikulina V.P., Kravchenko N.I., Belevskiy A.S., Petrikov S.S.
|
| Vol 94, No 3 (2022) |
Predictors of dysfunction of the small respiratory tract in patients with asthma |
(Rus)
|
|
Yurenko A.V., Antonyuk M.V., Mineeva E.E., Gvozdenko T.A.
|
| Vol 94, No 3 (2022) |
Experience of using a triple fixed combination in the treatment of patients with chronic obstructive pulmonary disease |
(Rus)
|
|
Bolotova E.V., Dudnikova A.V., Shulzhenko L.V.
|
| Vol 94, No 3 (2022) |
Analysis of the dynamics of mortality from respiratory diseases in the Russian Federation for 2019–2020 |
(Rus)
|
|
Drapkina O.M., Samorodskaya I.V., Bolotova E.V., Dudnikova A.V.
|
| Vol 94, No 3 (2022) |
The role of artificial intelligence in assessing the progression of fibrosing lung diseases |
(Rus)
|
|
Speranskaia A.A.
|
| Vol 94, No 3 (2022) |
Analysis of predictors of response to anti-IgE therapy in patients with severe atopic bronchial asthma in real clinical practice |
(Rus)
|
|
Fomina D.S., Mukhina O.A., Lebedkina M.S., Gadzhieva M.K., Bobrikova E.N., Sinyavkin D.O., Parshin V.V., Chernov A.A., Belevskiy A.S.
|
| Vol 94, No 2 (2022) |
Assessment of ten-year dynamics of cases of hospitalizations of patients with peptic ulcer disease, chronic gastritis and chronic duodenitis |
(Rus)
|
|
Butov M.A., Zhestkova T.V., Esakova E.M., Efanova L.V.
|
| Vol 94, No 2 (2022) |
Characteristic of disorders of motor-evacuator activities of the stomach and intestinal in chronic duodenal insufficiency |
(Rus)
|
|
Vakhrushev Y.M., Busygina M.S., Vatulin V.V.
|
| Vol 94, No 2 (2022) |
Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases |
(Rus)
|
|
Lishchinskaya A.A., Knyazev O.V., Kagramanova A.V., Dudina G.A., Sabelnikova E.A., Li I.A., Noskova K.K., Bodunova N.A., Parfenov A.I.
|
| Vol 94, No 2 (2022) |
The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study |
(Rus)
|
|
Yakovenko E.P., Strokova T.V., Ivanov A.N., Iakovenko A.V., Gioeva I.Z., Aldiyarova M.A.
|
| Vol 94, No 2 (2022) |
The study of abdominal and parietal enteric microbiota in patients with non-alcoholic fatty liver disease |
(Rus)
|
|
Vakhrushev Y.M., Lukashevich A.P., Lyapina M.V.
|
| Vol 94, No 2 (2022) |
The role of the main risk factors and endocrine cells of the antrum of the stomach producing motilin in the occurrence of cholelithiasis |
(Rus)
|
|
Svistunov A.A., Osadchuk M.A., Mironova E.D., Guliaev P.V., Vasileva I.N.
|
| Vol 94, No 2 (2022) |
CYP2D6 gene polymorphic markers role in determining the optimal treatment tactics for portal hypertension in patients with liver cirrhosis |
(Rus)
|
|
Sychev D.A., Parusov A.I., Loranskaya I.D., Denisenko N.P., Akmalova K.A., Sozaeva Z.A., Turkina O.L., Zastrozhin M.S.
|
| 151 - 200 of 428 Items |
<< < 1 2 3 4 5 6 7 8 9 > >>
|
